The Trump administration has made a groundbreaking move by reclassifying medical marijuana as a “less-dangerous drug,” easing federal restrictions and paving the way for expanded patient access. This shift marks a significant milestone in the evolution of U.S. drug policy
France is taking significant steps toward legalizing medical cannabis, with government officials advancing discussions around its regulation. This move could provide patients with easier access to cannabis for therapeutic purposes, signaling a shift in national health policy.
In a controversial statement, a Trump adviser claimed the existence of secret fentanyl labs in Canada to justify proposed tariffs. This allegation raises serious questions about the administration’s approach to drug trafficking and international trade relations.
